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Background: Primary maternal infection with cytomegalovirus (CMV), parvovirus B19 (B19V), and varicella-zoster
virus (VZV) may result in adverse pregnancy outcomes like congenital infection or foetal loss. Women working in
child day care have an increased exposure to CMV, B19V, and VZV. By comparing the seroprevalence of IgG-class
antibodies against CMV, VZV and B19V in female day care workers (DCW) with the seroprevalence in women not
working in day care this study aimed to assess the association between occupation and infection.
Methods: A cross-sectional design was used. Out of a random sample of 266 day care centres, demographic data,
data on work history, and blood samples were collected from 285 women from 38 centres. In addition, blood
samples and basic demographics from women who participated in a cross-sectional survey of the Amsterdam
population (2004) were used. All blood samples were tested for IgG-class antibodies against CMV, B19V, and VZV.
Results: Twenty-seven percent of the DCW were still susceptible to B19V or CMV. Working in day care was
independently associated with B19V infection in all DCW (prevalence ratio [PR] 1.2; 95 % CI 1.1–1.3), and with CMV
infection in DCW of European origin only (PR 1.7; 95 % CI 1.3–2.3). Almost all women born outside Europe tested
seropositive for CMV (96 %). All DCW tested seropositive for VZV, compared to only 94 % of the women not
working in day care.
Conclusion: This study confirms the clear association between employment in child day care centres and infection
with CMV and B19V. Intervention policies, like screening of new employees and awareness campaigns emphasizing
hygienic measures among DCW, should be implemented urgently to improve the maternal health of these women
and the health of their offspring.
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Primary maternal infection with cytomegalovirus
(CMV), parvovirus B19 (B19V), and varicella-zoster
virus (VZV) may result in adverse pregnancy outcomes
like congenital infection or foetal loss [1-4]. CMV is the
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distribution, and reproduction in any mediumto 1.0 % of all live births worldwide. It may lead to per-
manent disabilities in the unborn child, such as deafness,
blindness and mental impairments [5]. Primary CMV in-
fection results in life-long latent infection, and although
congenital infection after reactivation and re-infection
with a different CMV strain may occur, the risk of con-
genital infection is highest for seronegative women [6,7].
It is difficult to identify an acute CMV infection because
the disease is asymptomatic in 90 % of individuals and
the clinical signs, if present, are non-specific. In contrast,
primary VZV infection almost always causes signs ofCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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called chickenpox [3]. Primary maternal infection with
VZV during the first 20 weeks of pregnancy only, can
lead to foetal varicella syndrome in 1 % to 2 % of the
patients, but perinatal infection can also be harmful to
the newborn [3,4,8]. Like VZV, the risk of congenital
B19V infection depends on the gestational age, with the
greatest risk following maternal infection in the first
20 weeks. In about 5–10 % of pregnant women with pri-
mary B19V infection, transplacental transmission may
lead to adverse pregnancy outcome like hydrops foetalis
or foetal death [3,9]. After primary VZV or B19V infec-
tion, immunity is regarded as life-long [3,9].
In the Netherlands, most people experience primary
CMV, B19V, and VZV infection during their childhood.
Vaccination against VZV is not part of the national
childhood vaccination program. The identification of
risk groups susceptible to these infections is important
to assess the risk of infection in pregnant women. The
risk of exposure is generally present as CMV, B19V, and
VZV circulate widely in the population, but is particu-
larly high in child day care centres and schools. Children
attending day care have significantly higher rates of
CMV excretion in their saliva and urine, compared to
children not attending day care [10,11]. Outbreaks of
VZV and B19V occur regularly in day care centres and
schools. Employees of day care centres, most of whom
are women of childbearing age, are repeatedly exposed
to CMV, B19V, and VZV and, therefore, are considered
at risk [10,12-14]. The purpose of this study was to pro-
vide current estimates of the seroprevalence of IgG-class
antibodies against CMV, VZV, and B19V in women of
childbearing age working in child day care centres in
Amsterdam (DCW). By comparing these seroprevalence
rates with data from Amsterdam women not working in
day care, we aimed to assess the association between oc-
cupation and infection in DCW. Additionally, other
likely determinants of seropositivity for CMV, B19V, and
VZV, such as age and ethnic origin, were investigated.
Methods
Study population and sampling procedure
Child day care workers
Data on child day care personnel were obtained through
a cross-sectional survey carried out in 2007 by the Pub-
lic Health Service of Amsterdam (GGD Amsterdam).
Out of 266 day care centres on the Amsterdam munici-
pal register, a random sample of 63 was drawn. All 63
centres were invited to participate, with a response rate
of 60 %. Thirty-eight centres were then visited; all female
employees present were invited to participate, and nearly
all agreed, yielding a total of 285 participants. After giv-
ing informed consent, the participants were questioned
via a standardized face-to-face interview concerningsocio-demographics, family size, work history, and a
blood sample was collected. The samples were centri-
fuged and frozen at −80 °C within 48 h. The following
variables were considered pertinent to the study: sex,
age, country of birth of the participant and her parents,
when applicable the age at the time of immigration, the
number and age of children living with the participant
currently and/or in the past, and the number of years
working as a child care worker. In the analysis only
women of childbearing age (16 to 44 years) were
included (n = 242).
Women not working in child day care
Data on women not working in day care came from a
cross-sectional survey of the adult Amsterdam general
population, the Amsterdam Health Monitor (AHM), car-
ried out by the Public Health Service of Amsterdam in
2004 from which a serum repository was established.
AHM data was collected using frequency stratification
by ethnic group, and women of Turkish and Moroccan
origin were oversampled. Seroprevalence reported for
this group in our study did not account for the sampling
method of the AHM and basic demographic data and
blood samples from all female participants in that survey
aged 18 to 44 years (n = 298) were included. It should
not be considered as representative of women in the
Amsterdam general population, but rather as represen-
tative of women not working in child day care. More
information on the AHM and its serum repository is
described elsewhere [15-17]. Approval for both studies
was obtained from the Medical Ethics Committee of the
Academic Medical Centre.
Serological assays
All serum samples were tested for IgG-class antibodies
against B19V by means of quantitative enzyme immu-
noassays (NovaLisa™ Parvovirus B19 recombinant IgG-
ELISA; Novatec Immundiagnostica Gmbh.; Dietzenbach,
Germany). In calculating seroprevalence, samples with a
positive result (cut-off≥ 9 NovaTec Units) were consid-
ered immune.
IgG-class antibodies against CMV were determined by
a quantitative enzyme immunoassay (SERION ELISA
classic Cytomegalovirus IgG/IgM; Institut Virion/Serion,
Würzburg, Germany). Equivocal test results were con-
sidered seropositive.
Serum samples obtained from DCW were tested for
IgG-class antibodies against VZV with quantitative en-
zyme immunoassays (SERION ELISA classic Varicella-
Zoster-Virus IgG/IgM/IgA; Institut Virion/Serion,
Würzburg, Germany). To estimate VZV seropositivity in
women in the Amsterdam repository, plasma samples
were used and tested for IgG-class antibodies against
VZV with a microplate enzyme-linked immunosorbent
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-Virus IgG-ELISA; Medizinische Labordiagnostika AG,
Lübeck, Germany). Only women whose samples had a
positive result (cut-off ≥ 110 mIU/ml) were considered
immune. All assays were performed in the Public Health
Laboratory in Amsterdam according to the instructions
of the manufacturer.
Statistical analysis
Prevalences (P) were compared using the chi-square test;
values of p< 0.05 were considered significant. Univari-
able and multivariable binominal regression analysis,
adjusted for day-care centre clustering, was used to esti-
mate prevalence ratios (PR) with 95 % confidence inter-
vals (CI) based on robust standard errors. If significant
at univariable level (p< 0.1), covariates were included in
a multivariable model. In the analysis the AHM data
were not corrected for the sampling method. All ana-
lyses were performed in Intercooled Stata 11.1 for Win-
dows (Stata Corp., College Station, Texas, USA).
Results
Characteristics of the study sample
Table 1 shows the characteristics of the total of 540
women aged 16 to 44 years included in the analyses;
55 % (298) were women from the AHM, and 45 % (242)
were DCW. The median age was 32 years (interquartile
range [IQR] 25–39 years). The DCW were younger than
the women from the AHM (median age 29 years; IQR
24–35 years versus 35 years; IQR 28–40 years; rank sum
test, p< 0.001). Most women (294; 54 %) were born in
the Netherlands. Of the women born elsewhere, 37 %
originated from Turkey, 27 % from Morocco, 15 % from
Suriname or the Dutch Antilles, 10 % from within Eur-
ope and 11 % from other countries (Africa, Asia, Central
and South America). Most DCW were born in Europe
(77 %), whereas women from the Amsterdam Health
Monitoring Survey were more often born outside Eur-
ope (46 %). Most immigrants (59 %) arrived in the Neth-
erlands when they were adults; the median age at
migration was 20 years (range 1–42 years). Sixty-two per
cent of the women were mothers, 19 % had 1 child,
21 % had 2 children, and 14 % had 3 or more. The two
groups differed in that 84 % of the women of the AHM
had children compared to only 42 % of the DCW. Also,
84 % of all women born outside Europe had one or more
children compared to only 47 % of all women born in
the Netherlands or Europe (p< 0.001).
Seroprevalence of CMV IgG
No valid test results for CMV were available for 11
women (1 DCW and 10 from the general Amsterdam
population survey). The seroprevalence of CMV IgG
antibodies among the 529 women with valid test resultswas 73.0 % (95 % CI 69.0–76.7 %), and was similar
among DCW and among the women not working in day
care. Table 2 shows the seroprevalence by demographic
characteristics and the PR from univariable analysis.
Seroprevalence was significantly higher among immi-
grants born outside Europe (96 %) compared to women
born in European countries, including the Netherlands
(57 %). Nearly all of the women born in Turkey (99 %),
in Morocco (98 %), or in Suriname or the Dutch Antilles
(97 %) tested IgG-seropositive for CMV. Because the
seroprevalence of CMV in immigrants born outside Eur-
ope approached 100 %, a subgroup analysis limited to
the strata of women born in Europe was performed in a
separate multivariable binominal regression model. In
this model, after adjusting for working in child care, for
age (in categories), and for having children, CMV sero-
prevalence in DCW was significantly higher than among
women not working in day care centres (PR 1.7; 95 % CI
1.3–2.3; p< 0.001), and also among those having one or
more children of their own (PR 1.2; 95 % CI 1.1–1.4;
p = 0.03). (Data not shown).Seroprevalence of B19V IgG
The seroprevalence of B19V IgG antibodies among all
540 women was 65.9 % (95 % CI 61.8–69.9 %). The sero-
prevalence among DCW (73 %) was significantly higher
compared to the women not working in day care (60 %;
PR 1.2, 95 % CI 1.1–1.4; p = 0.003). Table 3 shows the
seroprevalence per variable, as well as the results of the
univariable and multivariable analyses. In a multivariable
model, working at a child care centre was an independ-
ent determinant of B19V IgG-seropositivity (PR 1.2,
95 % CI 1.1–1.3; p = 0.002). Also, in this model, being a
parent of one or more children was significantly asso-
ciated with B19V IgG-seropositivity (PR 1.2; 95 % CI
1.0–1.3; p = 0.02). No other independent risk factors
were identified.Seroprevalence of VZV antibodies IgG
All 540 women were tested for IgG antibodies against
VZV. The seroprevalence of VZV IgG antibodies in the
study sample was 96.5 % (95 % CI 94.6–97.7 %). All 242
DCW were seropositive for VZV IgG antibodies (95 %
CI 98.7–100.0 %), and although women from the Am-
sterdam general population had a high VZV IgG sero-
prevalence (93.6 %; 95 % CI 90.2–96.2 %), this was
significantly lower than among the DCW (p< 0.001). In
view of the 100 % VZV seropositivity among DCW, no
overall logistic regression analysis was performed. In a
multivariable model restricted to the women of Amster-
dam Health Monitoring Survey (no independent predic-
tors for seropositivity were found. (Data not shown).
Table 1 Characteristics of 242 female child day care workers in Amsterdam, The Netherlands, compared with 298






n % n % p value
Total 540 242 44.8% 298 55.2%
Age
Median age in years 32 (IQR 25–39) 29 (IQR 24–35) 35 (IQR 28–40) < 0.001
Age (in years) < 0.001
<20 23 4.3 % 11 4.6 % 12 4.0 %
20–24 92 17.0 % 51 21.1 % 39 13.1 %
25–29 107 19.8 % 69 28.5 % 40 13.4 %
30–34 90 16.7 % 48 19.8 % 42 14.1 %
35–39 108 20.0 % 30 12.4 % 78 26.2 %
40–44 120 22.2 % 33 13.6 % 87 29.2 %
Country of birth < 0.001
The Netherlands 294 54.4 % 176 72.7 % 118 39.6 %
Other European countries 25 4.6 % 11 4.6 % 14 4.7 %
Suriname and Dutch Antilles 37 6.9 % 26 10.7 % 11 3.7 %
Turkey 90 16.7 % 5 2.1 % 85 28.5 %
Morocco 66 12.2 % 15 6.2 % 51 17.1 %
Other countries 28 5.2 % 9 3.7 % 19 6.4 %
Country of birth by continent < 0.001
The Netherlands & Other European countries 319 59.1 % 187 77.3 % 132 44.3 %
Non-European countries* 221 40.9 % 55 22.7 % 166 55.7 %
Age at immigration < 0.001
0–17 years 97 40.9 % 27 44.3 % 70 39.6 %
18 and older 140 59.1 % 34 55.7 % 107 60.5 %
Data missing 9 – 5 – 4 –
Not applicable (born in the Netherlands) 294 – 176 – 118 –
Having children < 0.001
Yes 293 62.2 % 101 41.7 % 192 84.2 %
No 177 37.8 % 141 58.3 % 36 15.8 %
Data missing 70 – 0 – 70 –
Number of children < 0.001
0 177 32.8 % 141 58.3 % 36 12.1 %
1 104 19.3 % 46 19.0 % 58 19.5 %
2 113 20.9 % 35 14.5 % 78 26.2 %
3 76 14.1 % 20 8.3 % 56 18.8 %
Data missing 70 13.0 % 0 0 % 70 23.5 %
* Africa, Asia and Central and South America.
IQR; Interquartile range.
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This study demonstrates obvious differences in CMV,
B19V and VZV seroprevalence between women working
in Amsterdam day care centres and those who are not.
In the Netherlands a population-based percentage of
CMV seroprevalence is not available, yet the overall
CMV seroprevalence found in this study (73 %)corresponds to previous estimates in pregnant women in
the Amsterdam area [18]. In our study, CMV seropreva-
lence was strongly related to ethnic background; among
non-European women CMV seroprevalence was much
higher (96 %) than among European women (57 %) and
this difference was constant across all age groups. It is
well known that CMV seroprevalence varies worldwide,
Table 2 Prevalence of IgG antibodies against cytomegalovirus (CMV) by demographic characteristics in female child
day care workers (2007) in Amsterdam, The Netherlands, and in women of the Amsterdam population (2004) *
Characteristics
Study Sample CMV IgG Positive Univariable PR (95 % CI)
N n % p value p value
Total 529 386 73.0 %
Working in child day care 0.8
No 288 209 72.6 % 1
Yes 241 177 73.4 % 1.0 (0.9–1.1) 0.8
Age (in years) 0.08
16–24 110 80 72.3 % 1
25–34 199 135 67.8 % 0.9 (0.8–1.1) 0.4
35–44 220 171 77.7 % 1.1 (0.9–1.2) 0.3
Country of birth < 0.001
The Netherlands & Other European countries 313 178 56.9 % 1
Non-European countries** 216 208 96.3 % 0.6 (0.5–0.7) < 0.001
Age at immigration <0.001
0–17 years 95 88 92.6 % 1
18 and older 138 129 93.5 % 1.0 (0.9–1.1) 0.8
Data Missing 8 8 100 % –
Not applicable (born in the Netherlands) 288 161 55.9 % –
Having children < 0.001
No 175 113 64.6 % 1
Yes 288 236 81.9 % 1.3 (1.1–1.4) < 0.001
Data missing 66 39 56.1 % –
Number of children < 0.001
0 175 113 64.6 % 1
1 103 76 73.8 % 1.1 (1.0–1.3) 0.1
2 111 90 81.8 % 1.3 (1.1–1.5) 0.003
3 74 70 94.6 % 1.5 (1.3–1.7) < 0.001
Number of children missing 66 37 56.1 % –
* All analysis adjusted for day-care centre clustering.
** Africa, Asia and Central and South America.
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[19,20]. As a consequence of the very high CMV sero-
prevalence among non-European women, working in
day care appeared not to be related to CMV seropositiv-
ity in this group. However, within the group of women
of European origin, CMV seroprevalence differed consid-
erably between those working in child care (68 %; 95 %
CI 61–74 %) and those who were not (42 %; 95 % CI
32–50 %), and working in child care was independently
associated with CMV IgG-seropositivity (PR 1.7) among
European DCW. Whilst the same association was not
found for non-European DCW born (because of their
high background seropositivity), they surely have a simi-
lar occupational risk of (re-)infection to that of their
European colleagues.
Unlike CMV, in this study B19V seropositivity did not
depend on ethnic background, although worldwide geo-
graphic differences in B19V seroprevalence (with lower
B19V seroprevalence in tropical regions) are described[20]. The B19V seroprevalence in all women of child-
bearing age was 66 %, in line with previous estimates in
the overall Amsterdam population (61 %; 95 % CI 57–
64 %) [16]. However, DCW had a significantly higher
seroprevalence (73 %) compared to women not working
in day care (60 %). Apart from working with children
(PR 1.2), being a parent of one or more children was also
associated with B19V seropositivity (PR1.2).
In this study an association between working in day
care and VZV seroprevalence was not shown. Although
VZV seroprevalence differed significantly between DCW
(100 %) and women not working in child care (94 %) it
was not possible to control for likely confounders such as
age or ethnic background. Whereas VZV seroprevalence
in Dutch adults is nearly 95–100 %, which is typical for
adults born in a temperate climate, VZV seroprevalence
in immigrants from (sub)tropical countries is often lower
[21]. Remarkably, in this study all DCW, including immi-
grant DCW, tested positive for VZV. Although it seems
Table 3 Prevalence of IgG antibodies against parvovirus B19 by demographic characteristics in female day care
workers (2007) in Amsterdam, The Netherlands, and in women of the Amsterdam population (2004)*
Characteristics
Study Sample Parvovirus B19 IgG Positive Univariable PR (95 % CI) Multivariable PR (95% CI
N n % p value p value p value
Total 540 356 65.9 %
Working in child day care 0.003
No 298 180 60.4 % 1 1
Yes 242 176 72.7 % 1.2 (1.1–1.4) 0.002 1.2 (1.1–1.4) 0.002
Age (in years) 0.18
16–24 113 72 63.7 % 1 1
25–34 199 141 70.9 % 1.1 (1.0–1.3) 0.2 1.1 (0.9–1.3) 0.2
35–44 228 143 62.7 % 1.0 (0.8–1.2) 0.9 1.0 (0.8–1.3) 0.7
Country of birth 0.75
The Netherlands & Other European countries 319 212 66.5 % 1 1
Non-European countries** 221 144 65.2 % 1.0 (0.9–1.1) 0.73 1.1 (0.9–1.5) 0.08
Age at immigration 0.12
0–17 years 97 71 73.2 % 1
18 and older 141 88 62.4 % 0.9 (0.7–1.0) 0.07
Data missing 8 3 37.5 % –
Not applicable (born in the Netherlands) 294 194 66.0 % –
Having children 0.09
No 177 114 64.1 % 1 1
Yes 293 203 69.3 % 1.1 (0.9–1.2) 0.27 1.2 (1.0–1.3) 0.02
Data missing 70 39 55.7 % – –
Number of children 0.24 –
0 177 114 64.4 % 1
1 104 73 70.2 % 1.1 (0.9–1.3) 0.26
2 113 80 70.8 % 1.1 (0.9–1.3) 0.28
3 76 50 65.8 % 1.0 (0.8–1.2) 0.82
Number of children missing 70 39 55.7 % –
* All analysis adjusted for day-care centre clustering.
** Africa, Asia and Central and South America.
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contracted VZV after they started working in child care,
data on the incidence of chickenpox in this group were
not available, nor were data on the VZV serostatus at the
start of the women’s employment in child care. It is likely
that a boosting effect from the occupational exposure to
children infected by VZV has also contributed to the
100 % seropositivity found among DCW [22,23]. Lastly,
although the manufacturers of the two different enzyme
immunoassays (VIRION and EUROIMMUN) used for
the two serum samples groups quote similarly high sensi-
tivity (>94 %), a discrepancy between the two tests may
have affected the outcome.
A limitation in this study is that two demographically
different populations were studied. Although the multi-
variable regression models adjusted for some important
confounders like age, country of birth and having children,
it is possible that other confounders, like socio-economic
factors were missed. Also the sampling data of thepopulations differed (2004 and 2008), however the effect
of this difference is likely to be negligible.
Despite these limitations, our results confirm that
working in day care is independently associated with
CMV and B19V infection. Although the occupational
risk of infection in child care is not new and has been
described since the 1990’s [10,13,14,24-29], this know-
ledge has not contributed to the implementation of ef-
fective preventive policies for this particular risk group.
For VZV, a safe and effective vaccine is available and al-
though some countries have adopted guidelines to
screen and vaccinate risk groups (like healthcare work-
ers) this is not applicable to DCW [30,31]. As a conse-
quence, pregnant DCW exposed to chickenpox still
need very rapid testing, and seronegative women require
post-exposure prophylaxis with human varicella-human
immunoglobulin within 72 h. For CMV and B19V, vac-
cines are not available, although the development of a
vaccine against CMV is in progress [27,32]. Female
Rijckevorsel et al. BMC Public Health 2012, 12:475 Page 7 of 8
http://www.biomedcentral.com/1471-2458/12/475DCW should be considered a risk group eligible for vac-
cination once the vaccine becomes available. Until that
time, other preventive strategies are necessary, such as
awareness campaigns to ensure pregnant women are
alerted to the risks associated with exposure to CMV or
B19V. This is important as several studies have
described a lack of knowledge, not only among risk
groups, but also among physicians about the effects of
these infections during pregnancy [33-35]. Screening
should be considered, especially in those who are preg-
nant or are trying to become pregnant, as knowledge of
one’s serostatus might enhance the effect of behavioural
interventions and adherence to hygiene measures such
as hand washing after diaper changing. In addition, the
employer, the occupational physician, and the pregnant
employee who is susceptible to CMV or B19V infection
could agree on alternative work during at least part of
the pregnancy.
Conclusion
This study shows clearly the association between em-
ployment in child day care centres and CMV and B19V
infection. Also a considerable number of female DCW
of childbearing age remain susceptible to B19V infection.
To reduce the risk of congenital infection, widespread
implementation of intervention policies, like screening
of new employees (and if applicable, VZV vaccination),
behavioural interventions and awareness campaigns
among DCW, are strongly recommended to improve the
maternal health of these women and the health of their
offspring.
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